Quilalong, Vance Tyrell P.

HRN: 25-78-26  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2024
CEFUROXIME 1.5GM (VIAL)
08/28/2024
09/03/2024
IV
600mg
Q8
UTI
Waiting Final Action 
09/01/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/01/2024
09/08/2024
IV
250mg
Q24
Pcap C
Waiting Final Action 
09/02/2024
CEFTRIAXONE 1G (VIAL)
09/02/2024
09/09/2024
IV
1.7g
Q24hours
PCAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: